Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Kent

Showing results (151-160 of 390) with videos related to

Pageof 39
Sort By:
Vaccine|November 1, 2005
Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trialsBarbara E H Coupar, Damian F J Purcell, Scott A Thomson, et al.
The Journal of Infectious Diseases|April 28, 2018
A Lipid/DNA Adjuvant-Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus ChallengeTimothy D Carroll, Sinthujan Jegaskanda, Shannon R Matzinger, et al.
The European Respiratory Journal|January 22, 2021
Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequencesSheila K Patel, Jennifer A Juno, Wen Shi Lee, et al.
The Journal of Infectious Diseases|November 7, 2017
Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older AdultsHillary A Vanderven, Sinthujan Jegaskanda, Bruce D Wines, et al.
Plos One|June 16, 2012
Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cellsLeia Wren, Matthew S Parsons, Gamze Isitman, et al.
The Journal of Infectious Diseases|June 12, 2014
Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza virusesSinthujan Jegaskanda, Kirsten Vandenberg, Karen L Laurie, et al.
Plos One|November 4, 2008
Natural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaquesJoseph L Mankowski, Suzanne E Queen, Caroline S Fernandez, et al.
Immunogenetics|May 11, 2011
Screening and confirmatory testing of MHC class I alleles in pig-tailed macaquesCaroline S Fernandez, Jeanette C Reece, Uus Saepuloh, et al.
Vaccine|October 15, 2017
Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adultsFernanda Ana-Sosa-Batiz, Angus P R Johnston, P Mark Hogarth, et al.
Journal of Neurovirology|January 6, 2016
Central nervous system-specific consequences of simian immunodeficiency virus Gag escape from major histocompatibility complex class I-mediated controlSarah E Beck, Suzanne E Queen, Raphael Viscidi, et al.
Pageof 39

Showing results (151-160 of 390) with videos related to

Sort By:
Pageof 39
Vaccine|November 1, 2005
Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trialsBarbara E H Coupar, Damian F J Purcell, Scott A Thomson, et al.
The Journal of Infectious Diseases|April 28, 2018
A Lipid/DNA Adjuvant-Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus ChallengeTimothy D Carroll, Sinthujan Jegaskanda, Shannon R Matzinger, et al.
The European Respiratory Journal|January 22, 2021
Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequencesSheila K Patel, Jennifer A Juno, Wen Shi Lee, et al.
The Journal of Infectious Diseases|November 7, 2017
Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older AdultsHillary A Vanderven, Sinthujan Jegaskanda, Bruce D Wines, et al.
Plos One|June 16, 2012
Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cellsLeia Wren, Matthew S Parsons, Gamze Isitman, et al.
The Journal of Infectious Diseases|June 12, 2014
Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza virusesSinthujan Jegaskanda, Kirsten Vandenberg, Karen L Laurie, et al.
Plos One|November 4, 2008
Natural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaquesJoseph L Mankowski, Suzanne E Queen, Caroline S Fernandez, et al.
Immunogenetics|May 11, 2011
Screening and confirmatory testing of MHC class I alleles in pig-tailed macaquesCaroline S Fernandez, Jeanette C Reece, Uus Saepuloh, et al.
Vaccine|October 15, 2017
Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adultsFernanda Ana-Sosa-Batiz, Angus P R Johnston, P Mark Hogarth, et al.
Journal of Neurovirology|January 6, 2016
Central nervous system-specific consequences of simian immunodeficiency virus Gag escape from major histocompatibility complex class I-mediated controlSarah E Beck, Suzanne E Queen, Raphael Viscidi, et al.
Pageof 39